Market revenue in 2023 | USD 10.5 million |
Market revenue in 2030 | USD 75.4 million |
Growth rate | 32.5% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Therapeutics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Therapeutics, Diagnostics |
Key market players worldwide | Novartis AG ADR, Oncopeptides AB, Bicycle Therapeutics PLC ADR, AstraZeneca PLC, Theratechnologies Inc, Cybrexa Therapeutics, AngioChem, Soricimed |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peptide drug conjugates market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 81.9% in 2023. Horizon Databook has segmented the South Korea peptide drug conjugates market based on therapeutics, diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
The South Korea peptide drug conjugates market is anticipated to grow owing to increasing healthcare expenditure, favorable government initiatives, and a high burden of target diseases. Moreover, the peptide drug conjugate market in South Korea presents an intriguing competitive landscape marked by a blend of innovation and collaboration.
As the nation gains recognition as an R&D hub, both domestic and global pharmaceutical entities are engaging in strategic partnerships to capitalize on emerging opportunities. The market's competitive rivalry is driven by a convergence of academia, research institutions, and industry players.
This collaborative synergy is fostering an environment conducive to advancing peptide based therapeutics, with a particular focus on targeted treatments. Local companies are harnessing their expertise in peptide synthesis and drug delivery to carve a niche in this evolving sector.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea peptide drug conjugates market , including forecasts for subscribers. This country databook contains high-level insights into South Korea peptide drug conjugates market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account